Cawcutt, Kelly A. MD, MS; Kalil, Andre C. MD, MPH, FCCM
Both authors: Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE
*See also p. 337.
Dr. Cawcutt received funding from Becton, Dickinson and Company. Dr. Kalil has disclosed that he was an investigator for the National Institutes of Health Adaptive COVID-19 Treatment Trial.
